Innate Immune Cells in Melanoma: Implications for Immunotherapy

Area of Science:

• Immunology
• Oncology
• Dermatology

Background:

• The innate immune system comprises various cells like neutrophils, macrophages, and dendritic cells, acting as the body's first defense.
• Innate immunity significantly influences the initiation, progression, and prognosis of cutaneous malignant melanoma (MM).
• Melanoma is a common and increasingly prevalent skin cancer, characterized by high immunogenicity and significant mortality in its metastatic form.

Purpose of the Study:

• To review the multifaceted roles of innate immune cells in the context of melanoma.
• To explore the implications of innate immunity for the development and efficacy of melanoma immunotherapies.

Main Methods:

• This review synthesizes existing research on innate immunity and melanoma.
• It examines the contribution of various innate immune cells and their secreted factors.

Main Results:

• Innate immune cells, through cytokines and growth factors, impact melanoma pathogenesis and progression.
• The high mutational burden of melanoma contributes to its immunogenicity, a key factor in treatment responses.

Conclusions:

• Innate immunity is integral to melanoma's development and response to therapy.
• Further understanding of innate immune cell functions can optimize melanoma immunotherapy strategies.